Isthmusectomy in selected patients with well-differentiated thyroid carcinoma

Head Neck. 2020 Jan;42(1):43-49. doi: 10.1002/hed.25968. Epub 2019 Oct 7.

Abstract

Background: Isthmusectomy in the treatment of well-differentiated thyroid carcinoma (WDTC) is controversial. In this study, we analyze the outcomes of WDTC managed by isthmusectomy alone.

Methods: Forty-three patients treated with isthmusectomy alone were identified from an institutional database of 6259 surgically treated patients with WDTC. Patient and tumor characteristics were analyzed. Disease-specific survival (DSS) and recurrence-free survival (RFS) were calculated using the Kaplan-Meier method.

Results: The pT classification was T1 for 41 and T2 for two patients. All were clinical N0, but 10 pts were pN1a. Using the American Thyroid Association risk stratification system, 9 patients were low-risk and 22 were intermediate-risk. One patient developed local recurrence, and two developed regional lymph node metastases; the 5- and 10-year DSS was 100.0%. The 5- and 10-year RFS was 93.1%.

Conclusions: Isthmusectomy alone is an acceptable procedure in selected patients with low- and intermediate-risk WDTC limited to the isthmus.

Keywords: isthmectomy; isthmus; isthmusectomy; low risk cancer; well-differentiated thyroid carcinoma.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Papillary* / surgery
  • Humans
  • Neoplasm Recurrence, Local / surgery
  • Prognosis
  • Retrospective Studies
  • Thyroid Neoplasms* / surgery
  • Thyroidectomy